Tratamiento de obesidad, síndrome metabólico, diabetes tipo 2, enfermedades cardiovasculares, demencia, enfermedad de Alzheimer y enfermedad inflamatoria intestinal usando al menos una cepa bacteriana de Prevotella

• 收藏
• 分享

专利权人:

Proprev AB

发明人:

BJÖRCK, Inger,NILSSON, Anne,BÄCKHED, Fredrick,KOVATCHEVA-DATCHARY, Petia

申请号：

ES20140808269T

公开号：

ES2692162(T3)

申请日:

2014.05.27

申请国别(地区):

西班牙

年份:

2018

代理人:

摘要：

A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/